News

Do you have Nontuberculous
Mycobacterial (NTM) Pulmonary Disease?

Use pre-paid cards to support NTMir!

You can do your everyday shopping and great gift-giving while supporting NTM Info & Research! NTMir is able to sell gift cards with no activation fees to major national and regional retailers. In return, the retailers donate a percentage back to our...

Read More

NTM Patient Preferences Survey

On April 8th, 2019 the U.S. Food & Drug Administration will host a public workshop on the development of antibacterial drugs for the treatment of nontuberculous mycobacterial (NTM)...

Read More

Fitting Together the Pieces of the NTM Puzzle

Every day, NTM Info & Research’s commitment to finding therapies serves as hope for the NTM community. We are constantly looking for ways to boost our financial support of research to achieve better treatments and, eventually, a cure. Until that cure is found,...

Read More

How Can I Get a Prescription for ARIKAYCE®?

ARIKAYCE® is currently the only FDA approved drug designed specifically for NTM (MAC) and now available through prescription from your physician for treatment of refractory MAC lung infection in adult patients. This medication is only available through select...

Read More

Reflections on Our Physician/Patient Conference

Our continuing education-accredited conference is a groundbreaking opportunity for health care providers, researchers, patients, families, and caregivers to learn about the latest advances in research, treatment, and care from leaders in the field of nontuberculous...

Read More

220000

ESTIMATED CASES
OF NTM IN THE US
IN 2020

8.2 %

THE RISE IN THE
NUMBER OF NTM CASES
EACH YEAR

2.8m

ANTIBIOTIC-
RESISTANT INFECTIONS
IN THE US EACH YEAR